Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.41 |
| ▸ | TNKS | O95271 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29696841 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL21577244 | 0.97 | ALDH1A1 (0.62) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL261051 | 0.95 | MAPK1 (0.67) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL30114969 | 0.95 | MAPK1 (0.67) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL295925 | 0.93 | ALDH1A1 (0.71) | ALDH1A1MAPK1TDP1PTGS2KDM4E | |
| SCHEMBL4827207 | 0.93 | ALDH1A1 (0.50) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL13777182 | 0.92 | ALDH1A1 (0.55) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL3726098 | 0.90 | ALDH1A1 (0.52) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 | |
| SCHEMBL12795063 | 0.89 | ALDH1A1 (0.56) | ALDH1A1MAPK1PTGS2KDM4ECYP1A2 | |
| SCHEMBL18676097 | 0.89 | ALDH1A1 (0.46) | ALDH1A1MAPK1TDP1CYP2A6PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192692-A1 | MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF | TIANJIN NORMAL UNIVERSITY (CN) | 2023-06-22 | — | — | US | disclosed |
| EP-4194442-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | Novaled GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-11639339-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| US-11639339-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| EP-3406599-B1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| US-10991517-B2 | Molecular photon upconversion using organic-inorganic hybrid interfaces | The Florida State University Research Foundation, Inc. (US) | 2021-04-27 | — | — | US | disclosed |
| WO-2021073456-A1 | MACROCYCLIC AND CAGE-LIKE MOLECULES BASED ON BIPHENYLARENE AND DERIVATIVE COMPOUNDS, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 天津师范大学 | 2021-04-22 | — | — | WO | disclosed |
| CN-108165260-B | Organic electroluminescent material and preparation method and application thereof | 北京燕化集联光电技术有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-108129395-B | Organic electroluminescent material and preparation method and application thereof | 北京燕化集联光电技术有限公司 | 2020-09-15 | — | — | CN | disclosed |
| CN-108191766-B | Benzimidazole organic electroluminescent material and preparation method and application thereof | 北京燕化集联光电技术有限公司 | 2020-09-15 | — | — | CN | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| WO-2009077349-A1 | PROCESS FOR THE PREPARATION OF SEMICONDUCTING LAYERS | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
| US-7244518-B2 | Anthracene compounds and organic electroluminescent device employing the same | AU OPTRONICS CORP. (TW) | 2007-07-17 | — | — | US | disclosed |
| US-7244518-B2 | Anthracene compounds and organic electroluminescent device employing the same | AU OPTRONICS CORP. (TW) | 2007-07-17 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| WO-2007068618-A1 | ORGANIC SEMICONDUCTORS AND THEIR MANUFACTURE | CIBA HOLDING INC. (CH) | 2007-06-21 | — | — | WO | disclosed |
| EP-0786926-B1 | Light-emitting material for organo-electroluminescence device and organo-electroluminescence devive for which the light-emitting material is adapted | TOYO INK MFG CO (JP) | 2001-08-22 | — | — | EP | disclosed |
| US-5811834-A | Light-emitting material for organo-electroluminescence device and organo-electroluminescence device for which the light-emitting material is adapted | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| EP-0786926-A2 | Light-emitting material for organo-electroluminescence device and organo-electroluminescence devive for which the light-emitting material is adapted | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639339-B2 | Materials for organic electroluminescent devices | L1CAM, EFNA1, EPCAM | ALDH1A1 33/4885MAPK1 425/4885TDP1 1442/4885 |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ALDH1A1 2388/4885MAPK1 1300/4885TDP1 2598/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ALDH1A1 2388/4885MAPK1 1300/4885TDP1 2598/4885 |
| US-20230192692-A1 | MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF | TPMT, NUDT1, PNP | ALDH1A1 1259/4885MAPK1 4852/4885TDP1 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.